Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C

BACKGROUND: Direct acting antivirals (DAAs) are a very effective treatment for hepatitis C virus (HCV). However, brand DAAs are expensive. The licensing of cheaper generic DAAs may address this issue, but there is a lack of clinical studies comparing the efficacy of generic vs brand DAA formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Maheeba, Al Ghareeb, Aysha Mohamed, Husain, Hamed Ali Hasan Yusuf, Mohammed, Nafeesa, Al Qamish, Jehad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791528/
https://www.ncbi.nlm.nih.gov/pubmed/36579085
http://dx.doi.org/10.12998/wjcc.v10.i34.12566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791528/
https://www.ncbi.nlm.nih.gov/pubmed/36579085
http://dx.doi.org/10.12998/wjcc.v10.i34.12566

Ejemplares similares